Medical Associations Step In With Vaccine Guidance Amid Federal Inaction
Major U.S. medical organizations, including the AMA and the American Academy of Pediatrics, jointly issued recommendations urging most Americans to receive flu, COVID, and RSV vaccines for the upcoming season. The move comes as the Trump administration has not released federal vaccine guidance, a departure from historical practice. The groups also published summaries of vaccine safety and efficacy research in JAMA to support their recommendations.
The joint guidance marks an unusual shift, as private medical bodies have stepped in to fill a role traditionally held by the CDC. The consortium’s recommendations cover flu, COVID, and RSV, with specific data on reduced hospitalizations and deaths across age groups, including older adults, pregnant women, and infants. The accompanying JAMA summaries aim to counter declining public trust in vaccines, citing concrete efficacy figures such as a 53% reduction in COVID hospitalizations for adults over 65 and an 80% drop in flu-related deaths among children. The CDC has not yet launched its usual seasonal campaign, leaving the medical community to communicate risks and benefits directly to the public.
This development could reshape how Americans perceive vaccine guidance, as trust in federal agencies may be waning. The shift may lead to fragmented messaging, with some relying on medical associations while others remain skeptical. Vulnerable groups—older adults, pregnant women, and infants—could face higher risks if uptake declines, potentially increasing hospitalizations and deaths. However, the joint effort may also bolster credibility by presenting evidence transparently, possibly encouraging informed decisions. The long-term impact depends on whether federal guidance resumes and how effectively these organizations reach diverse communities.